OPPClass II
Pump, Infusion, Insulin Bolus
21 CFR 880.5725 / General Hospital
OPP is the FDA product code for Pump, Infusion, Insulin Bolus, a class II device type, regulated under 21 CFR 880.5725. FDA's definition for this code reads: "The device is adhered to the body for several days for the purpose of periodically infusing an insulin bolus". As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- OPP
- Device name
- Pump, Infusion, Insulin Bolus
- FDA definition
- The device is adhered to the body for several days for the purpose of periodically infusing an insulin bolus.
- Regulation
- 21 CFR 880.5725
- Device class
- Class II
- Review panel
- General Hospital
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 7
- Ingested recalls
- 1
Clearances, product code OPP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2010 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Applicants with the most clearances
Product code OPP| Applicant | Clearances |
|---|---|
| Calibra Medical, Inc. | 3 |
| CeQur SA | 3 |
| Lifescan Europe, A Division of Cilag GmbH | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
